Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christos Iliopoulos

Showing results (11-20 of 26) with videos related to

Pageof 3
Sort By:
Molecules (Basel, Switzerland)|February 12, 2020
Synthesis of Functionalized CannabilactonesYingpeng Liu, Thanh C Ho, Mohammed Baradwan, et al.
Oral Oncology|January 6, 2016
Prognostic significance of macrophage polarization in early stage oral squamous cell carcinomasManuel Weber, Christos Iliopoulos, Patrick Moebius, et al.
Molecular Pharmacology|September 24, 2022
Differential Enantiomer-Specific Signaling of Cannabidiol at CB<sub>1</sub> ReceptorsTaryn Bosquez-Berger, Sierra Wilson, Christos Iliopoulos-Tsoutsouvas, et al.
Behavioural Pharmacology|March 15, 2022
Altered sleep during spontaneous cannabinoid withdrawal in male miceGalen Missig, Niyati Mehta, James O Robbins, et al.
European Journal of Pharmacology|December 7, 2023
Effects of cannabinoid agonists and antagonists in male rats discriminating the synthetic cannabinoid AM2201Dalal AlKhelb, Emily L Burke, Alexander Zvonok, et al.
Receptors (Basel, Switzerland)|May 16, 2025
Comparison of Agonist Activity between CB1 and CB2 Receptors with Orthosteric Site MutationsChristina A Brust, Matthew A Swanson, Christos Iliopoulos Tsoutsouvas, et al.
Research Square|June 3, 2024
Structural basis of Δ<sup>9</sup>-THC analog activity at the Cannabinoid 1 receptorDavid Gloriam, Thor Thorsen, Yashraj Kulkarni, et al.
European Journal of Medicinal Chemistry|January 20, 2022
Improved cyclobutyl nabilone analogs as potent CB1 receptor agonistsIoannis P Papanastasiou, Markos-Orestis Georgiadis, Christos Iliopoulos-Tsoutsouvas, et al.
Nature Communications|January 8, 2025
Structural basis of THC analog activity at the Cannabinoid 1 receptorThor S Thorsen, Yashraj Kulkarni, David A Sykes, et al.
Journal of Medicinal Chemistry|March 24, 2021
Novel Functionalized Cannabinoid Receptor Probes: Development of Exceptionally Potent AgonistsShan Jiang, Christos Iliopoulos-Tsoutsouvas, Fei Tong, et al.
Pageof 3

Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
Molecules (Basel, Switzerland)|February 12, 2020
Synthesis of Functionalized CannabilactonesYingpeng Liu, Thanh C Ho, Mohammed Baradwan, et al.
Oral Oncology|January 6, 2016
Prognostic significance of macrophage polarization in early stage oral squamous cell carcinomasManuel Weber, Christos Iliopoulos, Patrick Moebius, et al.
Molecular Pharmacology|September 24, 2022
Differential Enantiomer-Specific Signaling of Cannabidiol at CB<sub>1</sub> ReceptorsTaryn Bosquez-Berger, Sierra Wilson, Christos Iliopoulos-Tsoutsouvas, et al.
Behavioural Pharmacology|March 15, 2022
Altered sleep during spontaneous cannabinoid withdrawal in male miceGalen Missig, Niyati Mehta, James O Robbins, et al.
European Journal of Pharmacology|December 7, 2023
Effects of cannabinoid agonists and antagonists in male rats discriminating the synthetic cannabinoid AM2201Dalal AlKhelb, Emily L Burke, Alexander Zvonok, et al.
Receptors (Basel, Switzerland)|May 16, 2025
Comparison of Agonist Activity between CB1 and CB2 Receptors with Orthosteric Site MutationsChristina A Brust, Matthew A Swanson, Christos Iliopoulos Tsoutsouvas, et al.
Research Square|June 3, 2024
Structural basis of Δ<sup>9</sup>-THC analog activity at the Cannabinoid 1 receptorDavid Gloriam, Thor Thorsen, Yashraj Kulkarni, et al.
European Journal of Medicinal Chemistry|January 20, 2022
Improved cyclobutyl nabilone analogs as potent CB1 receptor agonistsIoannis P Papanastasiou, Markos-Orestis Georgiadis, Christos Iliopoulos-Tsoutsouvas, et al.
Nature Communications|January 8, 2025
Structural basis of THC analog activity at the Cannabinoid 1 receptorThor S Thorsen, Yashraj Kulkarni, David A Sykes, et al.
Journal of Medicinal Chemistry|March 24, 2021
Novel Functionalized Cannabinoid Receptor Probes: Development of Exceptionally Potent AgonistsShan Jiang, Christos Iliopoulos-Tsoutsouvas, Fei Tong, et al.
Pageof 3